Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Calcium for Sarcopenia
ChiCTR2300069441Phase 4Not yet recruiting
- Sponsor
- PLA 967th Hospital
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of calcium in Sarcopenia (2 arms), sponsored by PLA 967th Hospital. Primary endpoints: Skeletal muscle index (SMI), Muscle strength measurement (handgrip strength) and 1 more. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
calcium
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on ChiCTR2300069441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069441.